Review
doi: 10.3322/canjclin.57.1.7.
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
Affiliations
- PMID: 17237032
- DOI: 10.3322/canjclin.57.1.7
Item in Clipboard
Review
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
CA Cancer J Clin.
2007 Jan-Feb.
Free article
Abstract
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.
Similar articles
-
From the American Cancer Society: vaccines to prevent cervical cancer.CA Cancer J Clin. 2007 Jan-Feb;57(1):29. doi: 10.3322/canjclin.57.1.29. CA Cancer J Clin. 2007. PMID: 17237033 No abstract available.
-
Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):e1-13; quiz e14-7. doi: 10.1331/JAPhA/2008.07032. J Am Pharm Assoc (2003). 2008. PMID: 18192123 Review.
-
Human papillomavirus, current vaccines, and cervical cancer prevention.J Obstet Gynecol Neonatal Nurs. 2009 Jan-Feb;38(1):69-80. doi: 10.1111/j.1552-6909.2008.00304.x. J Obstet Gynecol Neonatal Nurs. 2009. PMID: 19208050 Review.
-
[Consensus on the efficacy evaluation of HPV prophylactic vaccine clinical trials].Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):552-4. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24257312 Chinese. No abstract available.
-
Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.Minerva Med. 2007 Apr;98(2):121-30. Minerva Med. 2007. PMID: 17519854
Cited by
-
Regulation of Biobanks in Italy.Front Pediatr. 2020 Sep 2;8:415. doi: 10.3389/fped.2020.00415. eCollection 2020. Front Pediatr. 2020. PMID: 32984196 Free PMC article.
-
Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.J Clin Oncol. 2020 Sep 1;38(25):2892-2901. doi: 10.1200/JCO.19.02026. Epub 2020 Jun 18. J Clin Oncol. 2020. PMID: 32552278 Free PMC article.
-
Human papillomavirus vaccination: a case for mandatory immunization?J Pediatr Pharmacol Ther. 2008 Jan;13(1):47-50. doi: 10.5863/1551-6776-13.1.47. J Pediatr Pharmacol Ther. 2008. PMID: 23055864 Free PMC article. No abstract available.
-
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States.BMJ. 2009 Oct 8;339:b3884. doi: 10.1136/bmj.b3884. BMJ. 2009. PMID: 19815582 Free PMC article.
-
The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells.Cell Mol Biol Lett. 2011 Sep;16(3):477-92. doi: 10.2478/s11658-011-0018-8. Epub 2011 Jul 18. Cell Mol Biol Lett. 2011. PMID: 21786035 Free PMC article.
